S&P 500

5.346,99

-0,11%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Sophiris Bio Inc (SPHS)
Sophiris Bio Inc (SPHS) Notícias

SPHS

Sophiris Bio (SPHS)

Sophiris Bio Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:SPHS

1 2 3 4 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
11/03/2020	17:11	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SPHS	Sophiris Bio Inc
14/02/2020	16:36	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:SPHS	Sophiris Bio Inc
23/12/2019	18:14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SPHS	Sophiris Bio Inc
13/11/2019	08:01	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:SPHS	Sophiris Bio Inc
08/11/2019	18:09	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SPHS	Sophiris Bio Inc
21/10/2019	09:00	PR Newswire (US)	Sophiris Bio Receives Positive Feedback from FDA Regarding Phase 3 Localized Prostate Cancer Clinical Trial Design	NASDAQ:SPHS	Sophiris Bio Inc
08/10/2019	17:06	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:SPHS	Sophiris Bio Inc
06/09/2019	18:22	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:SPHS	Sophiris Bio Inc
06/09/2019	16:03	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:SPHS	Sophiris Bio Inc
30/08/2019	09:00	PR Newswire (US)	Sophiris Bio Announces Completion of $4.0 Million Registered Direct Offering	NASDAQ:SPHS	Sophiris Bio Inc
30/08/2019	09:00	PR Newswire (US)	Sophiris Bio to Present at the H.C. Wainwright 21st Annual Global Investment Conference	NASDAQ:SPHS	Sophiris Bio Inc
28/08/2019	07:04	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:SPHS	Sophiris Bio Inc
27/08/2019	09:12	PR Newswire (US)	Sophiris Bio Announces $4.0 Million Registered Direct Offering	NASDAQ:SPHS	Sophiris Bio Inc
19/06/2019	09:30	PR Newswire (US)	Sophiris Bio Receives Positive Feedback from European Medicines Agency Regarding Phase 3 Localized Prostate Cancer Clinical T...	NASDAQ:SPHS	Sophiris Bio Inc
09/05/2019	17:05	PR Newswire (US)	Sophiris Bio Reports First Quarter 2019 Financial Results	NASDAQ:SPHS	Sophiris Bio Inc
30/04/2019	17:13	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:SPHS	Sophiris Bio Inc
30/04/2019	17:11	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:SPHS	Sophiris Bio Inc
02/04/2019	17:05	PR Newswire (US)	Sophiris Bio to Present at Two Upcoming Investor Conferences	NASDAQ:SPHS	Sophiris Bio Inc
13/03/2019	18:02	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:SPHS	Sophiris Bio Inc
13/03/2019	17:05	PR Newswire (US)	Sophiris Bio Reports Fourth Quarter 2018 and Year-end Financial Results and Recent Corporate Highlights	NASDAQ:SPHS	Sophiris Bio Inc
21/12/2018	19:51	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:SPHS	Sophiris Bio Inc
17/12/2018	11:00	PR Newswire (US)	Sophiris Bio Provides Updates on Phase 2b Localized Prostate Cancer Trial	NASDAQ:SPHS	Sophiris Bio Inc
15/11/2018	19:05	PR Newswire (US)	Sophiris Bio to Present at the Piper Jaffray Healthcare Conference	NASDAQ:SPHS	Sophiris Bio Inc
13/11/2018	19:05	PR Newswire (US)	Sophiris Bio Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights	NASDAQ:SPHS	Sophiris Bio Inc
25/09/2018	09:00	PR Newswire (US)	Sophiris Bio to Present at the Cantor Global Healthcare Conference	NASDAQ:SPHS	Sophiris Bio Inc
20/09/2018	14:33	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:SPHS	Sophiris Bio Inc
14/09/2018	09:00	PR Newswire (US)	Sophiris Bio Extends the Interest Only Period under its Loan and Security Agreement	NASDAQ:SPHS	Sophiris Bio Inc
29/08/2018	17:30	PR Newswire (US)	Sophiris Bio to Present at the H.C. Wainwright 20th Annual Global Investment Conference	NASDAQ:SPHS	Sophiris Bio Inc
29/08/2018	09:00	PR Newswire (US)	Sophiris Bio Updates on Phase 2b Localized Prostate Cancer Trial	NASDAQ:SPHS	Sophiris Bio Inc
14/08/2018	17:05	PR Newswire (US)	Sophiris Bio Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights	NASDAQ:SPHS	Sophiris Bio Inc